Hyperphosphataemia - A silent killer of patients with renal failure?

Nephrology Dialysis Transplantation

Volumn 14, Issue 9, 1999, Pages 2085-2087

  Amann, Kerstin ^a   Gross, Marie Luise ^a   London, Gérard M ^b   Ritz, Eberhard ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Hopital Manhes   (France)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATE;

ATHEROSCLEROTIC PLAQUE; DISEASE ASSOCIATION; EDITORIAL; HUMAN; HYPERPHOSPHATEMIA; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL;

ANIMALS; CALCINOSIS; CARDIOMYOPATHIES; HUMANS; KIDNEY FAILURE, CHRONIC; MYOCARDIUM; PHOSPHATES;

EID: 0032805581     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.9.2085     Document Type: Editorial

References (22)

1. Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, Jacobs C. Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 1982; 31: 103-110
2. Kaminki MV Jr, Lowrie EG, Rosenblatt SG, Haase T. Malnutrition is lethal, diagnosable, and treatable in ESRD patients. Transplant Proc 1991; 23: 1810-1815
3. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 1996; 7: 728-736
4. Block G, Hulbert-Shearon T, Levin N et al. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysed patients: a nation study. Am J Kidney Dis 1998; 31: 607-617
5. Levin NW, Hulbert-Shearon TE, Strawderman RL. Which causes of death are related to hyperphosphataemia in hemodialysis (HD) patients? J Am Soc Nephrol 1998; 9: 217A
6. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999; 340: 115-126
7. Achenbach S, Moshage W, Ropers D, Nossen J, Daniel WG. Value of electron-beam computed tomography for the noninvasive detection of high-grade coronary-artery stenoses and occlusion. N Engl J Med 1998; 31: 1964-1971
8. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 1998; 31: 1972-1978
9. Clyne N, Lins LE, Pehrsson SK. Occurrence and significance of heart disease in uraemia. An autopsy study. Scand J Urol Nephrol 1986; 20: 307-311
10. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996; 27: 394-40138
11. Amann K, Schwarz U, Törnig J, Stein G, Ritz E. Some cardiac abnormalities in renal failure. In: Hamburger J. (ed.) Actualités Néphrologiques Médecine-Sciences Flammarion, Paris: 1997; 1-15
12. Raine AE. Acquired aortic stenosis in dialysis patients. Nephron 1994; 68: 159-68
13. Mucsi I, Herez G. Control of serum phosphate in patients with renal failure - new approaches. Nephrol Dial Transplant 1998; 13: 2457-2460
14. Miyamoto K, Tatsumi S, Morita K, Takeda E. Does the parathyroid 'see' phosphate? Nephrol Dial Transplant 1998; 13: 2727-2729
15. Naveh-Many T, Sela-Brown A, Silver J. Protein-mRNA interactions in the regulation of PTH gene expression calcium and phosphate. Nephrol Dial Transplant 1999. in press
16. Baczynski R, Massry SG, Kohan R, Magott M, Saglikes Y, Brautbar N. Effect of parathyroid hormone on myocardial energy metabolism in the rat. Kidney Int 1985; 27: 718-725
17. Narang R, Ridout D, Noris C, Kooner JS. Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease. Int J Cardiol 1997; 60: 73-79
18. Amann K, Wiest G, Klaus G, Ritz E, Mall G. A role of parathyroidhormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 1994; 4: 1814-1819
19. Amann K, Törnig J, Flechtenmacher C, Nabokov A, Mall G, Ritz E. Blood pressure independent wall thickening of intramyocardial arterioles in experimental renal failure-evidence for a permissive action of PTH. Nephrol Dial Transplant 1995; 10: 2043-2048
20. Törnig J, Kugel B, El-Shakmak A et al. Effects of high- and low phosphate diet on cardiovascular changes in subtotally nephrectomized rats. Kidney Blood Press Res 1998; 21: 104
21. Marchais S, Metivier F, Guerin A, London GM. Association of phosphataemia with haemodynamic disturbances in end-stage renal disease. Nephrol Dial Transpl 1999; 14: 2178-2183
22. London GM. The concept of ventricular/vascular coupling: functional and structural alterations of the heart and arterial vessels go in parallel. Nephrol Dial Transplant 1998; 13: 250-253